Cramer Advises His Viewers On Gilead Sciences And Monsanto

Jim Cramer said on CNBC's Mad Money that Gilead Sciences, Inc. GILD is extremely undervalued, but he would rather buy Amgen, Inc.AMGN, because Gilead Sciences has to make an acquisition with the money it has on its balance sheet.

Cramer thinks the deal between Bayer and Monsanto Company MON isn't going to happen, because the farmers aren't going to let it happen.